Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in two major healthcare investor conferences this November. The company will present at the Guggenheim Securities Healthcare Innovation Conference on Monday, November 11, 2024, at 2:30 p.m. ET, and at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 8:30 a.m. GMT. Live webcasts of both presentations will be available on Travere's investor relations website, with replays accessible for up to 30 days after each event.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario questo novembre. L'azienda si presenterà alla Guggenheim Securities Healthcare Innovation Conference lunedì 11 novembre 2024, alle 14:30 ET, e alla Jefferies London Healthcare Conference mercoledì 20 novembre 2024, alle 8:30 GMT. Le trasmissioni web in diretta di entrambe le presentazioni saranno disponibili sul sito web dedicato alle relazioni con gli investitori di Travere, con repliche accessibili per un massimo di 30 giorni dopo ciascun evento.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en dos importantes conferencias para inversores del sector salud este noviembre. La compañía presentará en la Guggenheim Securities Healthcare Innovation Conference el lunes 11 de noviembre de 2024, a las 2:30 p.m. ET, y en la Jefferies London Healthcare Conference el miércoles 20 de noviembre de 2024, a las 8:30 a.m. GMT. Las transmisiones en vivo de ambas presentaciones estarán disponibles en el sitio web de relaciones con inversores de Travere, con repeticiones accesibles hasta 30 días después de cada evento.
Travere Therapeutics (NASDAQ: TVTX)는 이번 11월에 두 가지 주요 헬스케어 투자자 회의에 참여한다고 발표했습니다. 회사는 2024년 11월 11일 월요일 오후 2:30 ET에 Guggenheim Securities Healthcare Innovation Conference에서 발표하고, 2024년 11월 20일 수요일 오전 8:30 GMT에 Jefferies London Healthcare Conference에서 발표합니다. 두 발표의 실시간 웹캐스트는 Travere의 투자자 관계 웹사이트에서 이용 가능하며, 각 행사 후 30일 동안 재생할 수 있습니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à deux importantes conférences pour investisseurs dans le domaine de la santé ce mois de novembre. La société fera une présentation lors de la Guggenheim Securities Healthcare Innovation Conference le lundi 11 novembre 2024 à 14h30 ET, et à la Jefferies London Healthcare Conference le mercredi 20 novembre 2024 à 8h30 GMT. Des webdiffusions en direct des deux présentations seront disponibles sur le site internet de relations avec les investisseurs de Travere, avec des rediffusions accessibles jusqu'à 30 jours après chaque événement.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Gesundheitssektor für diesen November bekannt gegeben. Das Unternehmen wird am Montag, den 11. November 2024, um 14:30 Uhr ET auf der Guggenheim Securities Healthcare Innovation Conference und am Mittwoch, den 20. November 2024, um 8:30 Uhr GMT auf der Jefferies London Healthcare Conference präsentieren. Live-Webcasts beider Präsentationen sind auf der Investor-Relations-Website von Travere verfügbar, und die Wiederholungen sind bis zu 30 Tage nach jeder Veranstaltung zugänglich.
- None.
- None.
SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in November:
Guggenheim Securities Healthcare Innovation Conference
Monday, November 11, 2024, at 2:30 p.m. ET
Jefferies London Healthcare Conference
Wednesday, November 20, 2024, at 8:30 a.m. GMT
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
| Contact: | |
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the Guggenheim Securities Healthcare Conference in 2024?
What time is Travere Therapeutics (TVTX) presenting at the Jefferies London Healthcare Conference?
How long will the webcasts of Travere Therapeutics (TVTX) November 2024 investor presentations be available?
Where can I watch Travere Therapeutics (TVTX) November 2024 investor conference presentations?
